Закрытое акционерное общество "ФармФирма "Сотекс" (RU)
发明人:
Ляпунов Алексей Николаевич (UA),Безуглая Елена Петровна (UA),Прохорков Николай Алексеевич (RU),Шелудченко Ольга Сергеевна (RU)
申请号：
RU2013147281/15
公开号：
RU2013147281A
申请日:
2013.10.24
申请国别(地区):
RU
年份:
2015
代理人:
摘要：
1. The external agent for the treatment of diseases of joints and soft tissues, comprising a non-steroidal antiinflammatory agent and a pharmaceutically acceptable carrier, wherein the pharmaceutically acceptable base is a mixture of water, trometamol and N-methylpyrrolidone, and non-steroidal anti-inflammatory agent is in the form a true solution with the components osnovy.2. The external agent of claim 1, wherein the pharmaceutically acceptable base further comprises ethanol at a concentration of up to 60% .3. The external agent of claim 1 or 2, characterized in that it is made in the form of a solution for external application, ointments or gelya.4. The external agent of claim 1 or 2, characterized in that it is in the form gelya.5. The external agent of claim 1 or 2, characterized in that the nonsteroidal antiinflammatory agent is selected from the group consisting oxicams or koksiby.6. The external agent of claim 1 or 2, characterized in that the non-steroidal anti-inflammatory agent is contained in a concentration of from 0.5 to 5.0% .7. The external agent of claim 1 or 2, characterized in that as non-steroidal anti-inflammatory agent used meloksikam.8. The external agent of claim 1 or 2, characterized in that the trometamol is contained in a concentration of from 0.1 to 3.5%, and N-methylpyrrolidone - in a concentration of from 2.0 to 30% .9. The external agent of claim 1 or 2, characterized in that the pharmaceutically acceptable base further comprises a carbomer concentration of 0.5 to 5.0%.1. Наружное средство для лечения болезней суставов и мягких тканей, содержащее нестероидное противовоспалительное средство и фармацевтически приемлемую основу, отличающееся тем, что фармацевтически приемлемая основа представляет собой смесь воды, трометамола и N-метилпирролидона, а нестероидное противовоспалительное средство находится в виде истинного раствора с компонентами основы.2. Наружное средство по п.1, отличающееся тем, что фармацевтически приемлемая основа допол
